Modern Development in Sleep Medicine with Particular Reference to Zolpidem

  • Eva Pelzer


The introduction of benzodiazepines as hypnotic agents into sleep medicine in the 60s has revolutionized therapeutical approach in the insomniac patient. This is mainly due to the fact that this group of sleep-promoting substances — in contrast to the predecessors chloral, the first synthetic hypnotic, and barbiturates — has a very high therapeutic index (Parkes, 1985).


Chronic Obstructive Pulmonary Disease Sleep Medicine Respiratory Disturbance Index Chronic Insomnia Hypnotic Agent 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Albin, H., Vincon, G., Vincon, J., Hermann, P., Thiercelin, J.F., 1988, Study of pharmacokinetics of zolpidem in healthy volunteers after repeated administration: effect on antipyrine clearance, in: Imidazopyridines in sleep disorders, L.E.R.S. monograph series, Volume 6 (J.P. Sauvanet, S.Z. Langer, and P.L. Morselli, eds.), pp. 369–370, Raven, New York.Google Scholar
  2. Berlin, I., Warot, D., Hergueta, T., Molinier, P., Bagot, C., Puech, A.J., 1993, Comparison of the effects of zolpidem and triazolam on memory functions, psychomotor performances, and postural sway in healthy subjects, Journal of Clinical Psychopharmacology 13(2): 100–106.PubMedCrossRefGoogle Scholar
  3. Blois, R., Gaillard, J.M., Attali, P., and Coquelin, J.P., 1993, Effect of zolpidem on sleep in healthy subjects: A placebo-controlled trial with polysomnographic recordings, Clinical Therapeutics 5: 797–809.Google Scholar
  4. Bond, A. and Lader, M., 1981, After-effects of sleeping drugs, in: Psychopharmacology of sleep (D. Wheatley, ed.), pp. 177–197, Raven, New York.Google Scholar
  5. Burt, D.R. and Kamatchi, G.L., 1991, GABA A receptor subtypes: from pharmacology to molecular biology, FASEB J. 5:2916–2923.PubMedGoogle Scholar
  6. Cohn, M.A., 1983, Hypnotics and the control of breathing: A review, British Journal of Clinical Pharmacology 16: 245S–250S.PubMedCrossRefGoogle Scholar
  7. Cohn, M.A., 1993, Effects of zolpidem, codeine phosphate and placebo on respiration, a double-blind, cross-over study in volunteers, Drug Safety 9(4): 312–319.PubMedCrossRefGoogle Scholar
  8. CroweMcCann, C., Quera-Salva, M.A., Boudet, J., Frisk, M., Barthouil, P., Borderies, P., and Meyer, P., 1993, Effect of zolpidem during sleep on ventilation and cardiovascular variables in normal subjects, Fundam Clin Pharmacol 7:305–310.CrossRefGoogle Scholar
  9. Dolly, F.R. and Block, A.J., 1982, Effect of flurazepam on sleep-disordered breathing and nocturnal oxygen desaturation in asymptomatic subjects, American Journal of Medicine 73:239–243.PubMedCrossRefGoogle Scholar
  10. Evans, S.M., Funderburk, F.R., and Griffiths, R.R., 1990, Zolpidem and triazolam in humans: behavioral and subjective effects and abuse liability, The Journal of Pharmacology and Experimental Therapeutics. 255(3): 1246–1255.PubMedGoogle Scholar
  11. Gaillot, J., Heusse, D., Houghton, G.W., Marc-Aurele, J., and Dreyfus, J.F., 1983, Pharmacokinetics and metabolism of zopiclone, Pharmacology 27(Suppl. 2): 76–91.PubMedCrossRefGoogle Scholar
  12. Giusti, P. and Arban, R., 1993, Physiological and pharmacological bases for the diverse properties of benzodiazepines and their congeners, Pharmacological Research 27(3): 201–215.PubMedCrossRefGoogle Scholar
  13. Guilleminault, C., 1990, Benzodiazepines,-breathing, and sleep, Am Med 88(Suppl. 3A): 25S–28S.CrossRefGoogle Scholar
  14. Haefely, W., Kyburz, E., Gerecke, M., and Mohler, H., 1985, Recent advances in the molecular pharmacology of benzodiazepine receptors and in the structure—activity relationships of their agonists and antagonists, in: Advances in Drug Research, Volume 14 (B. Testa, ed.), pp. 165–322, Academic Press, London.Google Scholar
  15. Herrmann, W.M., Kubicki, S.T., Boden, S., Eich, F.X., Attali, P., and Coquelin, J.-P., 1993, Pilot controlled double-blind study of the hypnotic effects of zolpidem in patients with chronic “learned” insomnia: psychometric and polysomnographic evaluation, The Journal of International Medical Research 21: 306–322.PubMedGoogle Scholar
  16. Johnson, L.C. and Chernik, D.A., 1982, Sedative hypnotics and human performance, Psychopharmacology 76: 101–113.PubMedCrossRefGoogle Scholar
  17. Julou, L., Blanchard, J.C., and Dreyfus, J.F., 1985, Pharmacological and clinical studies of cyclopyrrolones: Zopiclone and suriclone, Pharmacol Biochem Behav 23: 653–659.PubMedCrossRefGoogle Scholar
  18. Kales, A., Scharf, M.B., and Kales, J.D., 1978, Rebound insomnia: A new clinical syndrome, Science 201: 1039–1040.PubMedCrossRefGoogle Scholar
  19. Kales, A., Scharf, M.B., Kales, J.D., and Soldatos, C.R., 1979, Rebound insomnia. A potential hazard following withdrawal of certain benzodiazepines, JAMA 241: 1692–1695.PubMedCrossRefGoogle Scholar
  20. Lader, M., 1992, Rebound insomnia and newer hypnotics, Psychopharmacology 108: 248–255.PubMedCrossRefGoogle Scholar
  21. Langer, S.Z. and Arbilla, S., 1988, Imidazopyridines as a tool for the characterization of benzodiazepine receptors: A proposal for a pharmacological classification as omega receptors, Pharmacol. Biochem. Behav. 29: 763–767.PubMedCrossRefGoogle Scholar
  22. Langtry, H.D. and Benfield, P., 1990, Zolpidem. Areview of its pharmacodynamic and pharmacokinetic properties and therapeutic potential, Drugs 40: 291–313.PubMedCrossRefGoogle Scholar
  23. Mendelson, W.B., 1990, Hypnotics in the treatment of chronic insomnia, in: Handbook of sleep disorders (M.J. Thorpy, ed.), pp. 737–753, Dekker, New York, Basel.Google Scholar
  24. Mendelson, W.B., Garnett, D., Gillin, C., 1981, Flurazepam-induced sleep apnea syndrome in a patient with insomnia and mild sleep-related respiratory changes, Journal of Nervous and Mental Diseases 4: 261–264.Google Scholar
  25. Monti, J.M., Attali, P., Monti, D., Zipfel, A., de la Giclais, B., and Morselli, P.L., 1994, Zolpidem and rebound insomnia — A double-blind, controlled polysomnographic study in chronic insomniac patients, Pharmacopsychiatry 27: 166–175.PubMedCrossRefGoogle Scholar
  26. Murciano, D., Armengaud, M.H., Cramer, P.H., Neveux, E., L’Héritier, C.L., Pariente, R., Aubier, M., 1993, Acute effects of zolpidem, triazolam and flunitrazepam on arterial blood gases and control of breathing in severe COPD, European Respiratory Journal 6: 625–629.PubMedGoogle Scholar
  27. Murphy, J.E. and Ankier, S.I., 1984, A comparison of hypnotic activity of loprazolam, flurazepam and placebo, British Journal of Clinical Practice 38: 141–149.PubMedGoogle Scholar
  28. Olsen, R.W. and Tobin, A.J., 1990, Molecular biology of GABA A/benzodiazepine receptors, FASEB J. 4: 1469–1480.PubMedGoogle Scholar
  29. Parkes, J.D., 1985, Sleep and its disorders, Saunders, Philadelphia.Google Scholar
  30. Patat, A., Naef, M.M., Van Gessel, E., Forster, A., Dubruc, C, and Rosenzweig, P., 1994, Flumazenil antagonizes the central effects of zolpidem, an imidazopyridine hypnotic, Clinical Pharmacology and Therapeutics 56: 430–436.PubMedCrossRefGoogle Scholar
  31. Polc, P., 1988, Electrophysiology of benzodiazepine receptor ligands: Multiple mechanisms and sites of action, Progress in Neurobiology 31: 349–424.PubMedCrossRefGoogle Scholar
  32. Quera-Salva, M.A., McCann, C., Boudet, J., Frisk, M., Borderies, P., and Meyer, P., 1994, Effects of zolpidem on sleep architecture, night time ventilation, daytime vigilance and performance in heavy snorers, British Journal of Clinical Pharmacology 37: 539–543.PubMedCrossRefGoogle Scholar
  33. Richens, A., Mercer, A.J., Jones, D.M., Griffiths, A., and Marshall, R.W., 1993, Effects of zolpidem on saccadic eye movements and psychomotor performance: a double-blind, placebo controlled study in healthy volunteers, British Journal of Pharmacology 36: 61–65.CrossRefGoogle Scholar
  34. Roger, M., Attali, P., and Coquelin, J.-P., 1993, Multicenter, double-blind, controlled comparison of zolpidem and triazolam in elderly patients with insomnia, Clin Therap 15(1): 127–136.Google Scholar
  35. Ruano, D., Khan, Z., de Blas, A.L., Machado, A., and Vitorica, J., 1994, Molecular heterogeneity of the typel GABA A/benzodiazepine receptor complex, European Journal of Pharmacology and Molecular Pharmacology 267: 123–128.CrossRefGoogle Scholar
  36. Ruano, D., Benavides, J., Machado, A., and Vitorica, J., 1995, Aging-associated changes in the pharmacological properties of the benzodiazepine (omega) receptor isotypes in the rat hippocampus, Journal of Neurochemistry 64: 867–873.PubMedCrossRefGoogle Scholar
  37. Sanger, D.J., Benavides, J., Perrault, G., Morel, E., Cohen, C, Joly, D., and Zivkovic, B., 1994, Recent developments in the behavioral pharmacology of benzodiazepine (omega) receptors: evidencs for the functional significance of receptor subtypes, Neuroscience and Biobehavioral Reviews 18(3): 355–372.PubMedCrossRefGoogle Scholar
  38. Scharf, M.B., Roth, T., Vogel, G.W., Walsh, J.K., 1994, A multicenter, placebo-controlled study evaluating zolpidem in the treatment of chronic insomnia, Journal of Clinical Psychiatry 55(5): 192–199.PubMedGoogle Scholar
  39. Shaw, S.H., Curson, H., and Coquelin, J.R, 1992, A double-blind, comparative study of zolpidem and placebo in the treatment of insomnia in elderly psychiatric in-patients, The Journal of International Medical Research 20: 150–161.PubMedGoogle Scholar
  40. Sicard, B.A., Trocherie, S., Moreau, J., Vieillefond, H., and Court, L.A., 1993, Aviation, Space and Environmental Medicine 64: 371–375.Google Scholar
  41. Sieghart, W., 1994, Pharmacology of benzodiazepine receptors: an update, Journal of Psychiatry and Neuroscience 19(1): 24–29.PubMedGoogle Scholar
  42. Steens, R.D., Pouliot, Z., Millar, T.W., Kryger, M.H., George, C.F., 1993, Effects of zolpidem and triazolam on sleep and respiration in mild to moderate chronic obstructive pulmonary disease, Sleep 16(4): 318–126.PubMedGoogle Scholar
  43. Steinberg, R., 1998, Benzodiazepine-receptor-agonists Zolpidem and Zopiclone tolerance and addiction potential, in: Sleep—wake disorders (K. Meier-Ewert and M. Okawa, eds.), pp. 191–199, Plenum, New York.Google Scholar
  44. Tada, K, Sato, Y., Sakai, T., Ueda, N., Kasamo, K., Kojima, T., 1994, Effects of zopiclone, triazolam, and nitrazepam on standing steadiness, Neuropsychobiology 29: 17–22.PubMedCrossRefGoogle Scholar
  45. Wickstrom, E. and Giercksky, K.E., 1980, Comparative study of zopiclone, a novel hypnotic, and three benzodiazepines, European Journal of Pharmacology 17: 93–99.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1997

Authors and Affiliations

  • Eva Pelzer
    • 1
  1. 1.Department of PsychiatryLudwig-Maximilians-UniversityMünickGermany

Personalised recommendations